Technology in Cancer Research & Treatment (Jan 2023)

Evaluation of Dose Calculation Based on Cone-Beam CT Using Different Measuring Correction Methods for Head and Neck Cancer Patients

  • Hanshun Gong MS,
  • Bo Liu PhD,
  • Gaolong Zhang PhD,
  • Xiangkun Dai MS,
  • Baolin Qu MD,
  • Boning Cai MD,
  • Chuanbin Xie MS,
  • Shouping Xu PhD

DOI
https://doi.org/10.1177/15330338221148317
Journal volume & issue
Vol. 22

Abstract

Read online

Purpose: To investigate and compare 2 cone-beam computed tomography (CBCT) correction methods for CBCT-based dose calculation. Materials and Methods: Routine CBCT image sets of 12 head and neck cancer patients who received volumetric modulated arc therapy (VMAT) treatment were retrospectively analyzed. The CBCT images obtained using an on-board imager (OBI) at the first treatment fraction were firstly deformable registered and padded with the kVCT images to provide enough anatomical information about the tissues for dose calculation. Then, 2 CBCT correction methods were developed and applied to correct CBCT Hounsfield unit (HU) values. One method (HD method) is based on protocol-specific CBCT HU to physical density (HD) curve, and the other method (HM method) is based on histogram matching (HM) of HU value. The corrected CBCT images (CBCT HD and CBCT HM for HD and HM methods) were imported into the original planning system for dose calculation based on the HD curve of kVCT (the planning CT). The dose computation result was analyzed and discussed to compare these 2 CBCT-correction methods. Results: Dosimetric parameters, such as the D mean , D max and D 5% of the target volume in CBCT plan doses, were higher than those in the kVCT plan doses; however, the deviations were less than 2%. The D 2% , in parallel organs such as the parotid glands, the deviations from the CBCT HM plan dose were less than those of the CBCT HD plan dose. The differences were statistically significant ( P < .05). Meanwhile, the V 30 value based on the HM method was better than that based on the HD method in the oral cavity region ( P = .016). In addition, we also compared the γ passing rates of kVCT plan doses with the 2 CBCT plan doses, and negligible differences were found. Conclusion: The HM method was more suitable for head and neck cancer patients than the HD one. Furthermore, with the CBCT HM -based method, the dose calculation result better matches the kVCT-based dose calculation.